JSKN003: clinical trials recruiting now
3
Recruiting trials
11
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Phase 3 2
Conditions being studied
Recruiting trials involving JSKN003
- Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
- JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast Cancer
- JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
Common questions
How many recruiting trials involve JSKN003?
3 recruiting trials across 11 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.